These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2585034)

  • 1. Skin and perivascular toxicity induced experimentally by doxorubicin.
    Balsari A; Lombardo N; Ghione M
    J Chemother; 1989 Oct; 1(5):324-9. PubMed ID: 2585034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental skin necrosis produced by adriamycin.
    Rudolph R; Suzuki M; Luce JK
    Cancer Treat Rep; 1979 Apr; 63(4):529-37. PubMed ID: 445507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathological changes in adriamycin extravasation injury.
    Emiroğlu M; Erçöçen AR; Demirseren ME; Yenidünya S; Edah N
    Ann Plast Surg; 1998 Jul; 41(1):103-4. PubMed ID: 9678481
    [No Abstract]   [Full Text] [Related]  

  • 4. Amelioration of doxorubicin-induced skin necrosis in mice by butylated hydroxytoluene.
    Daugherty JP; Khurana A
    Cancer Chemother Pharmacol; 1985; 14(3):243-6. PubMed ID: 3995685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin ameliorates doxorubicin-induced skin necrosis in rats.
    Kesik V; Kurt B; Tunc T; Karslioglu Y; Citak EC; Kismet E; Koseoglu V
    Ann Plast Surg; 2010 Aug; 65(2):250-3. PubMed ID: 20585237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of local steroid injection on rat skin lesions induced by extravasation of vesicant anticancer drugs].
    Sugimoto M; Yamamoto M; Mukouyama T; Ono C; Yasuda M; Shimada T; Suzuki T; Kamo N; Shiga C; Hosono H; Itagaki F; Watanabe M; Ikeda T
    Gan To Kagaku Ryoho; 2012 Apr; 39(4):577-82. PubMed ID: 22504681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of heparin fractions on the prevention of skin necrosis resulting from adriamycin extravasation: an experimental study.
    Askar I; Erbas MK; Gurlek A
    Ann Plast Surg; 2002 Sep; 49(3):297-301. PubMed ID: 12351979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long persistence of doxorubicin in human skin after extravasation.
    Sonneveld P; Wassenaar HA; Nooter K
    Cancer Treat Rep; 1984 Jun; 68(6):895-6. PubMed ID: 6733702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of growth factors on doxorubicin-induced skin necrosis: documentation of histomorphological alterations and early treatment by GM-CSF and G-CSF.
    Vargel I; Erdem A; Ertoy D; Pinar A; Erk Y; Altundag MK; Gullu I
    Ann Plast Surg; 2002 Dec; 49(6):646-53. PubMed ID: 12461449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extravasation injury potential of CI-980, a novel synthetic mitotic inhibitor.
    MacDonald JR; Pegg DG
    Cancer Chemother Pharmacol; 1993; 32(5):365-7. PubMed ID: 8339386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous ulceration due to contrast extravasation. Experimental assessment of injury and potential antidotes.
    Elam EA; Dorr RT; Lagel KE; Pond GD
    Invest Radiol; 1991 Jan; 26(1):13-6. PubMed ID: 2022447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment options in extravasation injury: an experimental study in rats.
    Yilmaz M; Demirdover C; Mola F
    Plast Reconstr Surg; 2002 Jun; 109(7):2418-23. PubMed ID: 12045569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ozone Ameliorates Doxorubicine-Induced Skin Necrosis - results from an animal model.
    Kesik V; Yuksel R; Yigit N; Saldir M; Karabacak E; Erdem G; Babacan O; Gulgun M; Korkmazer N; Bayrak Z
    Int J Low Extrem Wounds; 2016 Sep; 15(3):248-54. PubMed ID: 26286933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental model of doxorubicin extravasation in the mouse.
    Dorr RT; Alberts DS; Chen HS
    J Pharmacol Methods; 1980 Nov; 4(3):237-50. PubMed ID: 7442269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of DMSO and vitamin E to prevent doxorubicin skin ulceration in the mouse.
    Dorr RT; Alberts DS
    Cancer Treat Rep; 1983 May; 67(5):499-501. PubMed ID: 6850665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment methods for extravasations of chemotherapeutic agents: a comparative study.
    Loth TS; Eversmann WW
    J Hand Surg Am; 1986 May; 11(3):388-96. PubMed ID: 3711613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etiology and treatment of chemotherapeutic agent extravasation injuries: a review.
    Rudolph R; Larson DL
    J Clin Oncol; 1987 Jul; 5(7):1116-26. PubMed ID: 3298560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extravasation of chemotherapeutic agents.
    Hankin FM; Louis DS
    Am Fam Physician; 1985 Mar; 31(3):147-50. PubMed ID: 3976457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extravasation of dactinomycin, vincristine, and cisplatin: studies in an animal model.
    Buchanan GR; Buchsbaum HJ; O'Banion K; Gojer B
    Med Pediatr Oncol; 1985; 13(6):375-80. PubMed ID: 4046975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The limited role of corticosteroids in ameliorating experimental doxorubicin skin toxicity in the mouse.
    Dorr RT; Alberts DS; Chen HS
    Cancer Chemother Pharmacol; 1980; 5(1):17-20. PubMed ID: 7460191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.